Concepedia

Author

Jan Kuhlmann

University Medical Center Freiburg

Also Known As

J KUHLMANN, J. B. Kuhlmann, J. Kuhlmann, Jan B Kuhlmann, Jan B. Kuhlmann, Jan Kuhlmann

34

Publications

631

Citations

12

H-Index

30

Concepts

All Affiliations

University Medical Center FreiburgCharité - Universitätsmedizin BerlinHeidelberg UniversityUniversity of FreiburgNational Center for Tumor Diseases
JK

About

Jan Kuhlmann is an author at University Medical Center Freiburg specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

178

2

Health Sciences

2

2

31

3

Allergy

1

1

29

4

Biochemistry

1

1

29

5

Gastroenterology

1

1

18

Jan Kuhlmann

×

12

Publications

558

Citations

11

H-Index

YearCitations

Treatment of unresectable cholangiocarcinoma

Jan Kuhlmann, Wulf Euringer, Hans Christian Spangenberg,

European Journal of Gastroenterology & Hepatology

2012

120

Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study

Beate Schultheis, Gunnar Folprecht, Jan Kuhlmann,

Annals of Oncology

2013

90

PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO study

Arndt Vogel, Stefan Kasper, Michael Bitzer,

European Journal of Cancer

2018

63

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study

Beate Schultheis, Dirk Strumberg, Jan Kuhlmann,

Cancers

2020

58

DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study

K. Mross, Ulrike Fasol, Annette Frost,

Journal of Angiogenesis Research

2009

54

Esophageal involvement is frequent in lichen planus: study in 32 patients with suggestion of clinicopathologic diagnostic criteria and therapeutic implications

Johannes S. Kern, Kristin Technau‐Hafsi, H Schwacha,

European Journal of Gastroenterology & Hepatology

2016

48

A phase Ib/IIa study of combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma.

Beate Schultheis, Dirk Strumberg, Jan Kuhlmann,

Journal of Clinical Oncology

2016

42

Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype

Sonja K Rauchschwalbe, M Zühlsdorf, Georg Wensing,

International Journal of Clinical Pharmacology and Therapeutics

2004

29

Perioperative chemotherapy and cytoreductive surgery with versus without HIPEC in gastric cancer with limited peritoneal metastases: A randomized phase III study (GASTRIPEC).

Beate Rau, Markus Loeffler, Horst-Guenther Rau,

Journal of Clinical Oncology

2015

18

Panitumumab in combination with gemcitabine/cisplatin (GemCis) for patients with advanced kRAS WT biliary tract cancer: A randomized phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Arndt Vogel, Stefan Kasper, Wilko Weichert,

Journal of Clinical Oncology

2015

13

Page 1